BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 17725723)

  • 1. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center.
    Tenorio GC; Strauss RG; Wieland MJ; Behlke TA; Ludwig GA
    J Clin Apher; 2002; 17(4):170-6. PubMed ID: 12494409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality.
    Garner SF; Jones CI; Stephens J; Burns P; Walton J; Bernard A; Angenent W; Ouwehand WH; Goodall AH;
    Transfusion; 2008 Apr; 48(4):673-80. PubMed ID: 18194381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
    Alex J; Roberts B; Raife T
    J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort.
    Flesch BK; Adamzik I; Steppat D; Miller J; Carstensen L; Schapke M; Davey J
    Transfusion; 2010 Apr; 50(4):894-901. PubMed ID: 19951314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
    Cameron B; Rock G; Olberg B; Neurath D
    Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of defective high-shear platelet function among platelet donors.
    Harrison P; Segal H; Furtado C; Verjee S; Sukhu K; Murphy MF
    Transfusion; 2004 May; 44(5):764-70. PubMed ID: 15104660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vitro storage properties of Amicus apheresis platelets collected using single- and double-needle procedures from the same donors.
    Wagner SJ; Seetharaman S; Kurtz J
    Transfusion; 2012 Mar; 52(3):524-8. PubMed ID: 21880047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of plateletpheresis by donors with low-normal platelet counts.
    Rogers RL; Johnson H; Ludwig G; Winegarden D; Randels MJ; Strauss RG
    J Clin Apher; 1995; 10(4):194-7. PubMed ID: 8770712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections.
    Pitman JP; Basavaraju SV; Shiraishi RW; Wilkinson R; von Finckenstein B; Lowrance DW; Marfin AA; Postma M; Mataranyika M; Smit Sibinga CT
    Transfusion; 2015 Jul; 55(7):1685-92. PubMed ID: 25727921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
    Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
    Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
    Fontana S; Rados L; Schmid P; Leibundgut EO; Taleghani BM
    Transfusion; 2011 Sep; 51(9):2034-43. PubMed ID: 21438883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.